[ad_1]
Operator
Good afternoon, and welcome to the CelLBxHealth plc investor presentation. [Operator Instructions]
And I might now like handy you over to your CEO, Peter Collins. Good afternoon to you.
Peter Collins
Chief Govt Officer
Thanks. Good afternoon. Peter Collins, CEO at CelLBxHealth. I am trying ahead to share the most recent round how we’re shifting the corporate ahead with a brand new technique and marketing strategy.
On the decision immediately, with myself presenting; my colleague, Sinead Armstrong, our FD. Would you wish to introduce your self, Sinead?
Sinead Armstrong
Sure. Sinead Armstrong. I’ve been with CelLBx, previously ANGLE, during the last 25 years in numerous roles inside finance. Doing my present position for concerning the final 7 to eight years.
Peter Collins
Chief Govt Officer
Thanks, Sinead. Sadly, on this a part of the presentation, our Govt Chairman, Dr. Jan Groen, cannot be a part of us. However Jan has important expertise within the diagnostic trade. Some firms right here he is been concerned in establishing from Europe and efficiently transition them into the U.S. Two of them you’ll be able to see there with Agendia and the corporate MDxHealth. And Jan and I’ve beforehand labored collectively.
From my very own facet, I spent the final 25 years or so in senior government roles throughout both oncology, diagnostic or drug growth and, in lots of circumstances, each, that included — features a 5-year stint at GSK the place I headed diagnostics, reporting to the Board, but in addition was a part of their immunotherapy drug growth group. So seeing each side of the drug growth story.
And I spent the final 10 years in liquid biopsy, primarily
[ad_2]
